• 1. An anti-ultrasonic-stripping effect in confined micro/nanoscale cavities and its applications for efficient multiscale metallic patterning?
  Quan Xiang,Yiqin Chen,Zhiqin Li,Kaixi Bi,Guanhua Zhang,Huigao Duan Nanoscale, 2016,8, 19541-19550
• 2. An integrated process of CO2 capture and in situ hydrogenation to formate using a tunable ethoxyl-functionalized amidine and Rh/bisphosphine system?
  Yu-Nong Li,Liang-Nian He,Xian-Dong Lang,Xiao-Fang Liu,Shuai Zhang RSC Adv., 2014,4, 49995-50002
• 3. An intensified π-hole in beryllium-doped boron nitride meshes: its determinant role in CO2 conversion into hydrocarbon fuels?
  Luis Miguel Azofra,Douglas R. MacFarlane,Chenghua Sun Chem. Commun., 2016,52, 3548-3551
• 4. An astrophysically-relevant mechanism for amino acid enantiomer enrichment
  Stephen P. Fletcher,Richard B. C. Jagt,Ben L. Feringa Chem. Commun., 2007, 2578-2580
• 5. An artificial CO-releasing metalloprotein built by histidine-selective metallation?
  Inês S. Albuquerque,Hélia F. Jeremias,Miguel Chaves-Ferreira,Dijana Matak-Vinkovic,Omar Boutureira,Carlos C. Rom?o Chem. Commun., 2015,51, 3993-3996

Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate (CAS No. 169770-25-6): A Comprehensive Overview

Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate (CAS No. 169770-25-6) is a specialized organic compound that has garnered significant attention in the field of chemical and pharmaceutical research. This compound, characterized by its unique structural and chemical properties, plays a crucial role in various synthetic applications and potential therapeutic developments.

The molecular structure of Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate consists of an imidazole core substituted with a methyl group at the 1-position and a nitro group at the 4-position, further modified by a carboxylate ester group at the 2-position. This configuration imparts distinct reactivity and functionality, making it a valuable intermediate in organic synthesis and a candidate for further derivatization in medicinal chemistry.

In recent years, there has been a growing interest in imidazole derivatives due to their broad spectrum of biological activities. The nitro-substituted imidazole moiety, in particular, has been extensively studied for its potential pharmacological properties. Research has shown that such derivatives can exhibit antimicrobial, anti-inflammatory, and even anticancer effects. The presence of the ester group in Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate provides an additional handle for chemical modification, allowing for the exploration of novel analogs with enhanced biological activity.

One of the most compelling aspects of Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate is its utility as a building block in the synthesis of more complex molecules. The nitro group can be readily reduced to an amine, while the ester functionality can be hydrolyzed to yield a free carboxylic acid. These transformations open up numerous possibilities for creating structurally diverse compounds that can be screened for various biological activities.

The pharmaceutical industry has been particularly interested in exploring the potential of nitroimidazole derivatives as therapeutic agents. These compounds have shown promise in treating infections caused by anaerobic bacteria and protozoa. The structural motif of Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate aligns well with this class of drugs, suggesting that it could serve as a precursor for developing new antibiotics or antiparasitic agents.

Recent advancements in computational chemistry have also contributed to the study of Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate. Molecular modeling techniques have been employed to predict the binding modes of this compound with biological targets, providing insights into its potential mechanisms of action. These studies have helped researchers design more effective derivatives with improved pharmacokinetic properties.

The synthesis of Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate involves multi-step organic reactions that require careful optimization to achieve high yields and purity. Common synthetic routes include nitration of pre-existing imidazole derivatives followed by esterification. The choice of reagents and catalysts is critical to ensure regioselectivity and minimize side reactions.

In conclusion, Methyl 1-methyl-4-nitro-1H-imidazole-2-carboxylate (CAS No. 169770-25-6) is a versatile compound with significant potential in both academic research and industrial applications. Its unique structural features make it an attractive candidate for further development in medicinal chemistry, while its synthetic accessibility allows for rapid exploration of new derivatives. As research continues to uncover the biological activities of imidazole derivatives, compounds like this are poised to play a crucial role in the discovery and development of novel therapeutic agents.

• 3994-53-4(1-Methyl-5-nitro-1H-imidazole-2-carboxylic acid)
• 1563-98-0(Methyl 1-methyl-5-nitro-1H-imidazole-2-carboxylate)
• 683815-49-8(1-ethyl-5-nitro-1H-Imidazole-2-carboxylic acid ethyl ester)
• 73455-94-4(1-methyl-4-nitro-1H-Imidazole-2-carboxaldehyde)
• 109012-23-9(ethyl 1-methyl-4-nitro-imidazole-2-carboxylate)
• 1564-49-4(Ethyl 1-methyl-5-nitro-1H-imidazole-2-carboxylate)
• 109012-24-0(1-Methyl-4-nitro-1H-imidazole-2-carboxylic acid)
• 865998-46-5(Ethyl 5-nitro-1H-imidazole-2-carboxylate)
• 109012-22-8
• 683815-48-7(1-ethyl-4-nitro-1H-Imidazole-2-carboxylic acid ethyl ester)